112 results on '"Braekkan S"'
Search Results
2. PB1455 Incidence of Recurrence and Bleeding Rates in Isolated Superficial Vein Thrombosis. Findings from the TROLL Registry
3. OC 63.2 Plasma Expression Levels of microRNA-145 are Associated with Risk of Future Venous Thromboembolism
4. PB0949 Treatment Patterns in an Unselected Sample of Patients with Cancer Associated Thrombosis - Data from the TROLL Registry
5. OC 63.3 Combined Effect of High Factor VIII Levels and High Mean Platelet Volume on the Risk of Future Venous Thromboembolism
6. OC 40.1 Incidence of Bleeding and Recurrence in Isolated Distal Deep Vein Thrombosis. Findings from the TROLL Registry
7. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study
8. Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study
9. Recurrence and mortality after first venous thromboembolism in a large population‐based cohort
10. PO-17: Socioeconomic position and the risk of occult cancer in venous thromboembolism
11. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsφ Study
12. Obesity and risk of bleeding: the SMART study.
13. Impact of variants in the factor 5 gene on the risk of venous thromboembolism in cancer: OR393
14. Impact of inherited risk factors of venous thrombosis on the associations between family history of myocardial infarction and risks of myocardial infarction and venous thromboembolism: OR392
15. Survival after cancer-associated venous thrombosis: results from the Scandinavian Thrombosis and Cancer (STAC) study: OR345
16. Interrelation between cancer and myocardial infarction in the general population: OR293
17. Associations between atrial fibrillation and cause-specific risks of pulmonary embolism and stroke: OR267
18. Repeated measures of modifiable atherosclerotic risk factors over time and risk of myocardial infarction and venous thrombosis: OR254
19. Cohort profile: the Scandinavian Thrombosis and Cancer (STAC) Study: OR129
20. Unprovoked deep vein thrombosis is associated with future risk of disability pension: OR134
21. Red cell distribution width is associated with future risk of incident stroke: the Tromsø Study: OR120
22. Impact of incident myocardial infarction on future risk of venous thromboembolism: OR071
23. Regular physical activity and future risk of myocardial infarction and venous thrombosis - the tromsø study: OR075
24. Atrial fibrillation and future risk of venous thromboembolism:the Tromsφ study
25. Hyperglycemia, assessed according to HbA1c, and future risk of venous thromboembolism: the Tromsø study
26. Systemic hypoxia and risk of venous thromboembolism - the Tromsø study: PB 4.69–2
27. Impact of venous thromboembolism on future risk of atrial fibrillation - the Tromsø study: PB 4.64–2
28. Socioeconomic status and the risk of venous thromboembolism - the Tromsø study: PB 2.70–1
29. Impact of chronic obstructive pulmonary disease on future risk of venous thromboembolism in a general population - the Tromsø study: PB 1.69–4
30. Thyroid function, assessed by thyroid stimulating hormone, and future risk of venous thromboembolism -the Tromsø study: PB 1.70–1
31. Obesity measures and future risk of venous thromboembolism and myocardial infarction: PB 1.69–1
32. Height and risk of venous thromboembolism: a mendelian randomization study: PA 4.18–4
33. Venous thromboembolism and subsequent receipt of disability pension - a population-based prospective cohort study: PA 3.20–5
34. Impact of incident atrial fibrillation on future risk of venous thromboembolismthe Tromsø study: OC 59.6
35. Impact of incident venous thromboembolism on future risk of arterial thrombotic disease: OC 07.1
36. Platelet count measured prior to cancer development is a risk factor for venous thromboembolism in cancer patients - the Tromsø Study: OC 04.3
37. Cigarette smoking and the risk of venous thromboembolism: The Tromsφ Study
38. Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsφ
39. Monocyte count and procoagulant functions are associated with risk of venous thromboembolism: the Tromsφ study
40. Coffee consumption and the risk of venous thromboembolism: the Tromsφ study
41. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study
42. HDL-cholesterol and future risk of venous thromboembolism: the Tromsø Study
43. HDL cholesterol and future risk of venous thromboembolism - the tromso study: OC-TU-006
44. Taller men has increased risk of venous thromboembolism - the tromso study: OC-TU-005
45. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study
46. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study
47. Impact of Time Since Diagnosis and Mortality Rate on Cancer-associated Venous Thromboembolism in a General Population - The Scandinavian Thrombosis and Cancer (STAC) Cohort
48. Joint Effect between Smoking Status and Cancer on the Risk of Venous Thromboembolism:The Scandinavian Thrombosis and Cancer Cohort
49. Impact of Regular Physical Activity on the Risk of Cancer-related Venous Thromboembolism:- The Scandinavian Thrombosis and Cancer (STAC) Cohort
50. The european hematology association roadmap for european hematology research: A consensus document
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.